Samrat Pharmachem P/B Ratio
Samrat Pharmachem (SAMRATPH) P/B ratio is 0.91 (Low), book value per share ₹240.00 vs Healthcare average P/B of -0.94 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see SAMRATPH share price screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
SAMRATPH P/B Ratio — Valuation Insights & Book Value Analysis
Samrat Pharmachem price-to-book ratio interpretation, valuation status and historical context — current P/B 0.91 (Low). View SAMRATPH yearly price range for the annual high/low range and current price position.
- Stock appears undervalued with PB of 0.91, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 64.3% below historical average
- Trading at premium to sector average PB of -0.94
Samrat Pharmachem P/B Ratio Historical Trend
SAMRATPH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with SAMRATPH fair price to assess whether the stock is under or overvalued.
SAMRATPH Historical P/B Ratio — Book Value Per Share & Year-End Price
Samrat Pharmachem annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 0.95 | ₹240.0 | ₹227.30 | ₹72 | Low |
| 2024 | 1.77 | ₹216.67 | ₹382.65 | ₹65 | Moderate |
| 2023 | 1.66 | ₹210.0 | ₹348.20 | ₹63 | Moderate |
| 2022 | 4.85 | ₹156.67 | ₹759.50 | ₹47 | High |
| 2021 | 3.51 | ₹100.0 | ₹351.45 | ₹30 | High |
SAMRATPH vs Healthcare Peers — P/B Ratio Comparison
Samrat Pharmachem P/B 0.91 vs Healthcare average -0.94, median 0.6 — range -31.21–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -31.21 | ₹25 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.76 | ₹121 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |